Literature DB >> 8843071

Evidence for an early inflammatory response in the central nervous system of mice with scrapie.

S Betmouni1, V H Perry, J L Gordon.   

Abstract

In Alzheimer's disease, the most prevalent of the neurodegenerative diseases, inflammation of the CNS contributes to the pathology and is a target for therapy. In contrast, the group of neurodegenerative conditions known as the Prion Diseases have been widely reported as lacking any inflammatory elements despite the many similarities between the pathologies of Alzheimer's Disease and Prion Diseases We have found evidence for an inflammatory component in mouse scrapie, characterized by microglial activation and T-lymphocyte recruitment, which appears long before any clinical signs of the disease and spreads along well-defined anatomical pathways. These observations emphasize the potential value of murine scrapie as a model for studying the inflammatory pathology of other neurodegenerative diseases.

Entities:  

Mesh:

Year:  1996        PMID: 8843071     DOI: 10.1016/0306-4522(96)00212-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  54 in total

Review 1.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

2.  IL-1 family members as candidate genes modulating scrapie susceptibility in sheep: localization, partial characterization, and expression.

Authors:  Ane Marcos-Carcavilla; Jorge H Calvo; Carmen González; Katayoun Moazami-Goudarzi; Pascal Laurent; Maud Bertaud; Hélène Hayes; Anne E Beattie; Carmen Serrano; Jaber Lyahyai; Inmaculada Martín-Burriel; Estefânia Alves; Pilar Zaragoza; Juan J Badiola; Magdalena Serrano
Journal:  Mamm Genome       Date:  2007-01-22       Impact factor: 2.957

Review 3.  Microglia in prion diseases.

Authors:  Adriano Aguzzi; Caihong Zhu
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

Review 4.  Immune activation in brain aging and neurodegeneration: too much or too little?

Authors:  Kurt M Lucin; Tony Wyss-Coray
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

Review 5.  A rose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease.

Authors:  Monica J Carson; Tina V Bilousova; Shweta S Puntambekar; Benoit Melchior; Jonathan M Doose; Iryna M Ethell
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

6.  Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins.

Authors:  C K Combs; D E Johnson; S B Cannady; T M Lehman; G E Landreth
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

7.  Vaccination with an attenuated Creutzfeldt-Jakob disease strain prevents expression of a virulent agent.

Authors:  L Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

8.  Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines.

Authors:  Christopher J Henry; Yan Huang; Angela M Wynne; Jonathan P Godbout
Journal:  Brain Behav Immun       Date:  2008-09-12       Impact factor: 7.217

9.  Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping.

Authors:  Zuzana Sisková; Anton Page; Vincent O'Connor; Victor Hugh Perry
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

10.  Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation.

Authors:  Orla Cunningham; Suzanne Campion; V Hugh Perry; Carol Murray; Nicolai Sidenius; Fabian Docagne; Colm Cunningham
Journal:  Glia       Date:  2009-12       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.